Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined hepatitis B vaccines.

David FitzSimons1, Guido François, Nedret Emiroğlu

  • 1World Health Organization, Via Appia 20, 1211 Geneva, Switzerland.

Vaccine
|March 5, 2003
PubMed
Summary

Combined hepatitis B vaccines offer a strategic approach to immunization programs. Their review in Europe highlights safety, efficacy, and future prospects for broader vaccine impact.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same author

Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies.

Vaccine·2026
Same author

Towards elimination of viral hepatitis in the Czech Republic, Hungary, Poland and Slovakia: insights from the Viral Hepatitis Prevention Board (VHPB).

Clinical and experimental hepatology·2026
Same author

<i>Plasmodium falciparum</i> Malaria and Arbovirus Co-Exposure in the Boende Health Zone, Northwestern Democratic Republic of the Congo.

Tropical medicine and infectious disease·2026
Same author

Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey.

BMC infectious diseases·2026
Same author

Commentary: 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea.

Frontiers in public health·2026

Area of Science:

  • Vaccinology
  • Immunology
  • Public Health

Background:

  • Combined vaccines simplify immunization schedules, potentially increasing coverage rates.
  • The Viral Hepatitis Prevention Board (VHPB) convened to discuss hepatitis B vaccines.
  • Assessing existing and novel combined vaccines is crucial for public health strategies.

Purpose of the Study:

  • To review the status and impact of current and future combined hepatitis B vaccines.
  • To examine the safety, immunogenicity, and availability of hexavalent vaccines in Europe.
  • To evaluate the effect of combined vaccines on hepatitis B immunization programs and global impact.

Main Methods:

  • Review of available data on combined hepatitis B vaccines.
  • Analysis of safety and immunogenicity data for hexavalent vaccines (HepB, Hib, DTPa, IPV).
  • Examination of European licensing status and market availability.

Main Results:

  • Hexavalent vaccines combining hepatitis B, Hib, DTPa, and IPV antigens were presented.
  • Data on safety, immunogenicity, and European availability were discussed.
  • The impact on hepatitis B immunization programs and global added value were estimated.

Conclusions:

  • Combined hepatitis B vaccines present a valuable tool for enhancing immunization coverage.
  • Further development and strategic implementation of combined vaccines are recommended.
  • These vaccines are expected to significantly impact hepatitis B prevention efforts globally.

Related Experiment Videos